TechFlow, August 12 — According to CryptoBriefing, Peter Thiel's investment group, co-founder of PayPal and Palantir, has acquired a 7.5% stake in biotech company 180 Life Sciences (soon to be renamed ETHZilla). The company recently announced its transformation into an Ethereum treasury entity and completed the sale of $156 million in senior secured convertible notes. Previously, it also completed a private placement of $425 million.
This marks Thiel's investment group's second investment in the Ethereum treasury space. Earlier, the group acquired over 9% ownership in BitMine Immersion, currently the largest corporate holder of Ethereum, which manages approximately $5 billion in Ethereum assets.
Add to Favorites
Share to Social Media
